PFE : Analysis & Opinions

  • Showing 1-100 of 205 items
  • 1
  • 2
  • 3
  • >>
  1. Allergan: An Activist Investment Analysis (AGN,VRX)

    January 28, 2016
    Read about the activist investor campaign against Allergan by Bill Ackman. See how Ackman partnered with another drug company ...
  2. How the New Allergan Plc Will Make Money

    January 14, 2016
    Allergan plc is not only enormous, it's about to more than double in size. Here's why and how.
  3. Healthcare Stocks: Are These 2016's Best?

    January 13, 2016
    Healthcare stocks aren't likely to hold up as well as you think, but these three stocks could offer resiliency.
  4. The Biggest M&A Deals of 2015

    January 5, 2016
    Here is a summary of 2015 M&A activity and a look ahead at 2016.
  5. 5 Big M&A deals in 2015 (PFE, AGN)

    December 23, 2015
    Learn how these mergers and acquisitions helped make 2015 a boom year for M&A deals, with the total value of the companies ...
  6. Top 3 NYSE Listed Stocks for 2016 (BABA, PFE)

    December 23, 2015
    Learn about some of the stocks listed on the NYSE that may setting up for a big year in 2016. See how Alibaba has underperformed ...
  7. The World's Top 10 Biotechnology Companies (JNJ, ROG.VX)

    December 22, 2015
    Learn how the marriage of science and technology is changing the world of medicine and creating some of the largest multinational ...
  8. AstraZeneca Makes a $575 Million Acquisition (AZN, PFE)

    December 16, 2015
    Pharmaceutical giant AstraZeneca (NYSE: AZN) is shoring up its presence in a key segment. On Wednesday, the company announced ...
  9. The Top 5 Dividend Paying Healthcare Stocks for 2016 (JNJ, PFE)

    December 8, 2015
    Discover the top five dividend health care stocks for 2016, including two pharmaceutical giants and two newer dividend stocks ...
  10. M&A Hits a Record in 2015

    December 4, 2015
    2015 has been a record year for mergers and acquisitions as M&A activity hit record levels, fuelled by consolidation in various ...
  11. Retail Investors May Face Capital Gains Tax on Pfizer Allergan ...

    November 30, 2015
    The Pfizer-Allergan merger may end up costing retail investors a pretty penny, but they may be able to minimize their losses. ...
  12. The Biggest Risks of Investing in Pfizer Stock (PFE)

    November 25, 2015
    Learn the biggest potential risks that may affect the price of Pfizer's stock, complete with a fundamental analysis and review ...
  13. Why Are Pfizer And Allergan Talking About A Split Even Before ...

    November 24, 2015
    The proposed merger between Pfizer and Allergan might be headed towards a split in the future. Why?
  14. Positive GDP Number Increases Chance of Rate Hike

    November 24, 2015
    The chances for a December hike in interest rates became stronger this morning with an uptick in U.S. GDP numbers during ...
  15. Pfizer-Allergan Merger Makes Biggest Firm by Sales

    November 23, 2015
    On November 22, 2015, America’s Pfizer and Ireland’s Allergan received their board of directors’ approval to merge in what ...
  16. New Treasury Rules Won't Stop Corporate Inversions (PFE, AGN)

    November 20, 2015
    The US Treasury Department unveiled new rules to curb corporate inversions. But, they may not be enough.
  17. Pfizer and Allergan Talk Mammoth Healthcare Deal

    November 19, 2015
    Pharmaceutical giant Pfizer Inc. is in talks with Botox maker Allergan Plc, to buy the latter in a deal worth $150 billion.
  18. Pfizer - Allergan: Will This Deal Happen? (PFE, AGN)

    October 30, 2015
    The question for investors is: Will this deal happen?
  19. Target Fires First Shot in Holiday Wars at Wal-Mart

    October 30, 2015
    In a move that has threatened retail giant WalMart (WMT), Target (TGT) has announced that it will offer free shipping and ...
  20. The 5 Best Dividend Stocks in the Healthcare Sector (GSK, ABBV)

    October 7, 2015
    Learn about the top five dividend stocks of companies operating in the health care sector that generate substantial cash ...
  21. Are Drug Price Controls Viable in the U.S.? (IPXL, ABBV)

    September 24, 2015
    Are price controls on pharmaceuticals viable in the U.S.? What effect would they have on existing drug companies and their ...
  22. Pfizer Stock Is Like An Extended Release Drug

    August 12, 2015
    Pfizer is a leading research-driven pharmaceutical company, but how good is its financial health?
  23. Europe Regulator Approves Pfizer Buyout of Hospira (HSP, PFE)

    August 7, 2015
    Pfizer (NYSE: PFE) has gotten the green light from Europe's antitrust regulator to acquire fellow pharmaceutical Hospira ...
  24. 3 Reasons Pfizer Stock Could Rise (PFE)

    June 19, 2015
    Pfizer (NYSE: PFE) is truly facing a challenge of unprecedented magnitude at the moment. While patent issues are something ...
  25. Most Important Mergers And Acquisitions Of 2015

    June 15, 2015
    Nearly halfway through the year, 2015 is proving to be a big one for mergers and acquisitions.
  26. 3 Reasons Pfizer Stock Could Fall (PFE)

    June 12, 2015
    Pharmaceutical giant Pfizer (NYSE: PFE) has been something of an anomaly over the past couple of years. Despite facing an ...
  27. Billionaire Phillip Frost Is at It Again (OPK, BRLI)

    June 8, 2015
    Over the past 40 years, Phillip Frost became one of the most respected entrepreneurs in healthcare by cobbling together ...
  28. Pfizer CEO: The Story Behind Ian Read (PFE, AZN)

    June 3, 2015
    Learn about the rise of Ian Read, the CEO of Pfizer. Pfizer is one of the most profitable and largest pharmaceutical companies ...
  29. Top 10 Pfizer Venture Investments (PFE)

    June 2, 2015
    Learn more about Pfizer Venture Investments, a private equity venture capital firm, and some of the major companies in its ...
  30. Pfizer's Ibrance Takes Another Giant Leap Forward (PFE)

    June 1, 2015
    Although its stock price may not reflect it, the past four-plus years have been perhaps the most challenging in Pfizer's ...
  31. Is Pfizer's Dividend Built to Last? (PFE)

    May 27, 2015
    Pfizer (NYSE: PFE) is the prototypical Big Pharma giant. Among megacap pharmaceutical names, Pfizer generates more revenue ...
  32. Would Pfizer Buying GlaxoSmithKline Make Sense? (GSK, PFE)

    May 22, 2015
    Over the past five years, Pfizer (NYSE: PFE) and its shareholders have witnessed its stock price ascend by approximately ...
  33. Who are Gilead Sciences' (GILD) main competitors?

    May 22, 2015
    Learn about the pharmaceutical company Gilead Sciences and its main competitors. Explore the company's role in creating HIV-preventing ...
  34. Who are Pfizer's (PFE) main competitors?

    May 20, 2015
    Learn about Pfizer's place in the pharmaceutical industry, and find out which major drug manufacturers are among its main ...
  35. 5 Things Pfizer's Management Wants You to Know (PFE)

    May 18, 2015
    It's been just shy of three weeks since pharmaceutical juggernaut Pfizer (NYSE: PFE) reported its first-quarter earnings ...
  36. Pfizer's 3 Most Important Numbers (PFE)

    May 8, 2015
    Pfizer (NYSE: PFE) is one of the largest and most profitable pharmaceutical companies in the world. Last year alone, it ...
  37. A Quick Guide To Healthcare ETFs

    May 8, 2015
    The healthcare industry offers a broad variety of sector ETFs but it’s difficult to avoid exposure to pharmaceuticals and ...
  38. How China Makes Money (PFE, GSK)

    April 28, 2015
    China has the first or second largest GDP in the world but is not nearly as developed as others in the top 10.
  39. How to Analyze Pharma Stock Fundamentals

    April 23, 2015
    What you need to know about analyzing the fundamentals of pharma stocks.
  40. Pfizer Earnings Preview: 5 Things You Need to Know (PFE, HSP)

    April 21, 2015
    Pfizer may not be the growth giant it was when it was riding cholesterol-fighting drug Lipitor's coattails to success, but ...
  41. Is This Pfizer's Next Mega-Blockbuster Drug? (PFE)

    April 16, 2015
    In February, the FDA delivered Pfizer (NYSE: PFE) some welcome news when it gave the company the go-ahead to begin marketing ...
  42. 3 Moves Pfizer Should Make for Its Shareholders (PFE, JAZZ)

    April 7, 2015
    PFE data by YCharts. Big pharmaceutical giant Pfizer (NYSE: PFE) isn't often thought of as a substantial growth driver of ...
  43. Is This Pfizer's Single Best Chance for Growth? (PFE)

    April 3, 2015
    Pfizer (NYSE: PFE) is a drug-developing Goliath, but it's struggled over the past few years to offset a drop-off in sales ...
  44. What are examples of major companies in the drugs sector?

    April 1, 2015
    Identify the major players in the drugs sector, which include many established pharmaceutical companies that have delved ...
  45. The Future of Big Pharma Stocks

    March 31, 2015
    A look at the future health of big pharma stocks.
  46. Four Key Pharmaceuticals ETFs To Consider

    March 25, 2015
    ETF funds are now very liquid investments and are suitable to investors who seek to match the price performance of the indexes ...
  47. Why These ETFs are the Best Way to Trade Pfizer

    March 17, 2015
    Looking to play Pfizer with diversification? Consider these ETFs.
  48. How A Strong Greenback Affects the Economy

    March 2, 2015
    The fact that the strong dollar has an effect on the US economy is indisputable, but is the overall impact positive or negative? ...
  49. Interested In Pharmaceutical Stocks? Try Novartis (ADR)

    February 26, 2015
    Novartis AG, is the world's leading pharmaceutical company by sales. Here is a closer look at Novartis, and how its financials ...
  50. Warning: 5 Popular Stocks You Need To Sell Now

    February 11, 2015
    These are five of the most widely owned stocks in the market. You have, without a doubt, heard of them, and it's very possible ...
  51. Warning: 5 Popular Stocks You Need to Consider Selling Now

    February 11, 2015
    These are five of the most widely owned stocks in the market. You have, without a doubt, heard of them, and it's very possible ...
  52. How the S&P 500 and Russell 2000 Indexes Differ

    January 22, 2015
    The S&P 500 and Russell 2000 are used as benchmarks for broader segments of the U.S. stock market. Each index has its own ...
  53. The Best Way Into Big Pharma? See This ETF (IHE)

    November 21, 2014
    Pharma investing isn't for everyone, but sector-specific ETFs, such as the iShares Dow Jones U.S. Pharmaceuticals ETF (IHE), ...
  54. The Biggest Mergers & Acquisitions In The U.S.

    October 23, 2014
    M&A is a daily part of the American business world. They're based on the principle that "One plus one equals three," i.e. ...
  55. Profit From The Largest Generation In History: 2 Companies Boomers ...

    October 8, 2014
  56. How Merck Found Its Way Into Millions Of Medicine Cabinets

    September 15, 2014
    With over $40 billion in revenue from pharmaceutical sales, there's a good chance that you'll be very grateful for one of ...
  57. An Investing Legend Predicts A Major M&A Boom -- Here's How To ...

    August 7, 2014
    Some high-profile buyout deals have been falling apart lately. For instance, the third largest U.S. wireless carrier Sprint ...
  58. Why There's Far More To Pfizer Than Viagra

    July 30, 2014
    Pfizer, Inc. is one of the world's largest and most profitable pharmaceutical companies, and not just because of that little ...
  59. Interested In Healthcare Stocks? Look At This ETF

    July 3, 2014
    Healthcare companies seem to be poised to make a move higher over the months ahead. Here's an ETF that should be helpful ...
  60. Invest In Share Buybacks With This ETF

    June 13, 2014
    In most cases, when a company buys its own shares on the open market it's a signal to investors that they're undervalued. ...
  61. #PreMarket Primer: Tuesday, May 27: Hope Rises In Ukraine Despite ...

    May 27, 2014
    Following the election of billionaire Petro Poroshenko as President of Ukraine, diplomatic tensions seemed to be easing ...
  62. #PreMarket Primer: Monday, May 19: DirecTV Rises On Offer From ...

    May 19, 2014
    AT&T Inc. announced a deal to acquire DirecTV for $49 billion over the weekend, as the firm attempts to adapt to a quickly ...
  63. What Are The Best Bets In Biotech?

    May 2, 2014
    The NASDAQ Biotechnology Index is off nearly 20% as its components busy themselves with hostile bids and frenzied buying ...
  64. How Johnson & Johnson Became A Household Name

    April 21, 2014
    New Brunswick, N.J.-based Johnson & Johnson (NYSE:JNJ) is probably most famous as the parent company of multiple household ...
  65. Hedge Funds Love These 3 Pharma Stocks

    April 14, 2014
    In 2012, the star performer among sectors was the financial sector. In 2013, it was consumer discretionary stocks. For 2 ...
  66. These Companies Know The Future Before It Happens

    February 13, 2014
    Wouldn't it be great to have a crystal ball to see into the future?You could know when the next market crash will be, ...
  67. Gilead Sciences Leads In Rising Short Interest Among Biotechs

    November 12, 2013
    Among leading biotech and emerging pharmaceutical companies, the number of shares sold short in Alexion Pharmaceuticals ...
  68. It's No Accident That Drugs Are Expensive

    August 30, 2013
    Branded drugs are expensive in large part because it's expensive and risky to develop them
  69. Better Margins Can't Hide Merck's Growth Challenges

    July 30, 2013
    Merck's near-term growth is looking weak, but margin improvements and an underestimated pipeline could offer upside.
  70. Pfizer Looking A Little Tired

    July 30, 2013
    Pfizer gets a boost from better margins, but the growth outlook is pretty feeble.
  71. 8 Stages Of New Drug Development

    July 29, 2013
    Understanding biotech data isn't easy. What is a clinical trial, what are the various phases, and why do the results of these ...
  72. Wall Street Happy To Hum La AbbVie En Rose

    July 26, 2013
    AbbVie's pipeline is better than some think, but valuation is no particular bargain right now.
  73. Drugs Driving JNJ, With Slow Progress In Devices And Consumer

    July 17, 2013
    JNJ is getting great performance out of its drug business, but the remainder still lags.
  74. Short Interest in Biogen Idec and Vertex Shrinks (BIIB, CELG, ...

    June 26, 2013
    Among biotech and emerging pharmaceutical companies, Celgene (NASDAQ: CELG) and saw the most significant rise in short interest ...
  75. ViroPharma and Other Biotech Stocks Recommended by Oppenheimer ...

    June 24, 2013
    Oppenheimer has a new team of analysts focused on biotechnology and specialty pharmaceuticals. And, research from the new ...
  76. Big Pharma Faces 'Pay For Delay' Lawsuits

    June 21, 2013
    Unless you follow the pharmaceutical and biotech sectors, it’s likely that you’ve never heard of pay to delay. Instead of ...
  77. Make Money From Spinoffs

    June 4, 2013
    According to Barrons, 15 spinoffs have taken place in 2013 through the end of May, 50% more than last year. It seems all ...
  78. Alnylam Basking In Orphan Drug Attention

    May 28, 2013
    Alnylam has already seen a big run, but clinical success could bring even more gains.
  79. Coty Readies IPO

    May 28, 2013
    Fragrance maker Coty filed a registration statement amendment May 28 that sees it raising as much as $1.2 billion from its ...
  80. After A Big Rally, Pfizer Might Need Some Rest

    May 21, 2013
    A big rally has brought Pfizer back to fair value.
  81. Amgen Chased By The Bubble

    May 8, 2013
    Amgen really needs the pipeline to come through to support this valuation.
  82. The “Healthy” Play In Contract Research Organizations

    April 17, 2013
    The pharmaceutical industry is under pressure to do more with less. That means it will be farming out many of is mundane ...
  83. Pfizer Readies Zoetis For Market

    January 23, 2013
    Pfizer filed further details about its tentative spin-off of Zoetis, its animal health business.
  84. A Look Back At The Year In Pharmaceuticals

    December 28, 2012
    Pharmaceuticals have had a decidedly mixed year in 2012, largely on the basis of the revenue growth outlook.
  85. BASF's Deal For Pronova Shows The Importance Of Good Nutrition

    November 23, 2012
    BASF ties up another high-grade fish oil company in Pronovna, adding to the recent rise in popularity for the fish oil space.
  86. Endo Health Solutions Needs Some Solutions Of Its Own

    November 7, 2012
    Can Endo reestablish itself as a quality healthcare name?
  87. Bayer Buys Schiff Nutrition International: Winners All Around

    November 7, 2012
    Bayer announced November 2 that it's buying Schiff for $1.2 billion to bulk up its consumer business.
  88. Teva Likely To Tread Water Ahead Of New Strategy

    November 5, 2012
    Teva has restructuring and growth opportunities, but the risk is still elevated.
  89. Pfizer's Third Quarter Earnings Report

    November 1, 2012
    Pfizer (NYSE:PFE) announced its results for the most recent quarter on November 1, 2012. Pfizer is a global pharmaceutical ...
  90. Pfizer Third Quarter Earnings Preview

    October 25, 2012
    When Pfizer (NYSE:PFE) releases its third quarter earnings on Tuesday, October 30, 2012, analysts are expecting a 16.1% drop ...
  91. Drugs Have Moved J&J On To A New Phase

    October 17, 2012
    J&J is back on a growth track, but the device business needs fixing.
  92. Pfizer Is Near a Key Resistance Area

    September 27, 2012
    New York, September 27th (TradersHuddle.com) - Shares of Pfizer, Inc. (NYSE:PFE) are trading very close to calculated resistance ...
  93. Pfizer Looks To Spin Off Animal Health Unit

    August 15, 2012
    Pfizer has filed plans to sell up to 20% of its animal-health unit in the first half of 2013 to focus on human pharmaceuticals. ...
  94. The Week Ahead In Healthcare

    August 13, 2012
    The performance of healthcare stocks (as measured by ETFs) has begun to falter a bit, likely in part because Johnson & ...
  95. Huntington Launches Sector Rotation ETF (HUSE)

    July 30, 2012
    Huntington, fresh off its initial foray into the ETF industry in June, has doubled the size of its lineup with the launch ...
  96. Portfolio Pruning 101

    July 27, 2012
    MoneyShow's Tom Aspray takes an in-depth look at his successful Charts in Play Portfolio, as he looks to take profits on ...
  97. 4 Dividend ETFs With Higher Yields Than LQD

    July 24, 2012
    Once upon a time, the conventional wisdom was that investors should hold stocks as a source of long-term capital appreciation ...
  98. Is Pfizer Reversing?

    July 23, 2012
    New York, July 23rd (TradersHuddle.com) - Shares of Pfizer, Inc. (NYSE:PFE) closed the trading day lower by $0.1 or -0.4% ...
  99. The Most Overbought Dow Stocks

    July 3, 2012
    Despite large first-quarter gains, two big Dow stocks show strong monthly chart formations and are worthy of new buying. ...
  100. Dow 30 Stocks With High Dividends

    June 1, 2012
    We combed through the Dow 30 to find some of its highest-yielding stocks.
  • Showing 1-100 of 205 items
  • 1
  • 2
  • 3
  • >>
Trading Center